Minimally invasive assessment of hepatic function in children with indocyanine green elimination: a validation study

References

• Kim WR, Brown RS, Jr., Terrault NA, et al. Burden of liver disease in the United States: summary of a workshop. Hepatology. 2002;36:227–242.
   PubMed Web of Science ®Google Scholar
• Mohammad S, Kaurs E, Aguirre VP, et al. Health-related quality of life in infants with chronic liver disease. J Pediatr Gastroenterol Nutr. 2016;62:751–756
   PubMed Web of Science ®Google Scholar
• Squires RH, Jr., Shneider BL, Bucuvalas J, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148:652–658.
   PubMed Web of Science ®Google Scholar
• Hsu EM. Cirrhosis and chronic liver failure. In: Suchy FJ SR, Balistreri WF, editor. Liver disease in children. 4th edition. Cambridge, England: Cambridge University Press; 2014.
   Google Scholar
• Jain V, Dhawan A. Prognostic modeling in pediatric acute liver failure. Liver Transpl. 2016;22:1418–1430.
   PubMed Web of Science ®Google Scholar
• D'Souza RS, Neves Souza L, Isted A, et al. AST-to-platelet ratio index in non-invasive assessment of long-term graft fibrosis following pediatric liver transplantation. Pediatr Transplant. 2016;20:222–226.
   PubMed Web of Science ®Google Scholar
• Freeman RB, Jr., Wiesner RH, Roberts JP, et al. Improving liver allocation: MELD and PELD. Am J Transplant. 2004;4:114–131.
   PubMed Web of Science ®Google Scholar
• Liu E, MacKenzie T, Dobyns EL, et al. Characterization of acute liver failure and development of a continuous risk of death staging system in children. J Hepatol. 2006;44:134–141.
   PubMed Web of Science ®Google Scholar
• Caesar J, Shaldon S, Chiandussi L, et al. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci. 1961;21:43–57.
   PubMed Web of Science ®Google Scholar
• Levesque E, Martin E, Dudau D, et al. Current use and perspective of indocyanine green clearance in liver diseases. Anaesth Crit Care Pain Med. 2016;35:49–57.
   PubMed Web of Science ®Google Scholar
• Owens SL. Indocyanine green angiography. Br J Ophthalmol. 1996;80:263–266.
   PubMed Web of Science ®Google Scholar
• Pind ML, Bendtsen F, Kallemose T, et al. Indocyanine green retention test (ICG-r15) as a noninvasive predictor of portal hypertension in patients with different severity of cirrhosis. Eur J Gastroenterol Hepatol. 2016;28:948–954.
   PubMed Web of Science ®Google Scholar
• Sakka SG, Reinhart K, Meier-Hellmann A. Comparison of invasive and noninvasive measurements of indocyanine green plasma disappearance rate in critically ill patients with mechanical ventilation and stable hemodynamics. Intensive Care Med. 2000;26:1553–1556.
   PubMed Web of Science ®Google Scholar
• Cheung TT, Chan SC, Chok KS, et al. Rapid measurement of indocyanine green retention by pulse spectrophotometry: a validation study in 70 patients with Child–Pugh A cirrhosis before hepatectomy for hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2012;11:267–271.
   PubMed Web of Science ®Google Scholar
• Purcell R, Kruger P, Jones M. Indocyanine green elimination: a comparison of the LiMON and serial blood sampling methods. ANZ J Surg. 2006;76:75–77.
   PubMed Web of Science ®Google Scholar
• Sakka SG, Koeck H, Meier-Hellmann A. Measurement of indocyanine green plasma disappearance rate by two different dosages. Intensive Care Med. 2004;30:506–509.
   PubMed Web of Science ®Google Scholar
• de Liguori Carino N, O'Reilly DA, Dajani K, et al. Perioperative use of the LiMON method of indocyanine green elimination measurement for the prediction and early detection of post-hepatectomy liver failure. Eur J Surg Oncol. 2009;35:957–962.
   PubMed Web of Science ®Google Scholar
• Inal MT, Memiş D, Kargı M, et al. Prognostic value of indocyanine green elimination assessed with LiMON in septic patients. J Crit Care. 2009;24:329–334.
   PubMed Web of Science ®Google Scholar
• Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–310.
   PubMed Web of Science ®Google Scholar
• Imamura H, Sano K, Sugawara Y, et al. Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg. 2005;12:16–22.
   PubMedGoogle Scholar
• Faybik P, Krenn CG, Baker A, et al. Comparison of invasive and noninvasive measurement of plasma disappearance rate of indocyanine green in patients undergoing liver transplantation: a prospective investigator-blinded study. Liver Transpl. 2004;10:1060–1064.
   PubMed Web of Science ®Google Scholar
• Zipprich A, Kuss O, Rogowski S, et al. Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis. Gut. 2010;59:963–968.
   PubMed Web of Science ®Google Scholar
• Scheingraber S, Richter S, Igna D, et al. Indocyanine green elimination but not bilirubin indicates improvement of graft function during MARS therapy. Clin Transplant. 2007;21:689–695.
   PubMed Web of Science ®Google Scholar
• Merle U, Sieg O, Stremmel W, et al. Sensitivity and specificity of plasma disappearance rate of indocyanine green as a prognostic indicator in acute liver failure. BMC Gastroenterol. 2009;9:91.
   PubMed Web of Science ®Google Scholar
• Lisotti A, Azzaroli F, Cucchetti A, et al. Relationship between indocyanine green retention test, decompensation and survival in patients with Child–Pugh A cirrhosis and portal hypertension. Liver Int. 2016;36:1313–1321.
   PubMed Web of Science ®Google Scholar
• Lisotti A, Azzaroli F, Buonfiglioli F, et al. Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis. Hepatology. 2014;59:643–650.
   PubMed Web of Science ®Google Scholar
• Quintero J, Miserachs M, Ortega J, et al. Indocyanine green plasma disappearance rate: a new tool for the classification of paediatric patients with acute liver failure. Liver Int. 2014;34:689–694.
   PubMed Web of Science ®Google Scholar
• McDiarmid SV, Anand R, Lindblad AS, et al. Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation. 2002;74:173–181.
   PubMed Web of Science ®Google Scholar
• Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006;130:1652–1660.
   PubMed Web of Science ®Google Scholar
• Lichtinghagen R, Pietsch D, Bantel H, et al. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values. J Hepatol. 2013;59:236–242.
   PubMed Web of Science ®Google Scholar